Clinical Trials Directory

Trials / Unknown

UnknownNCT04883567

The Use of AI to Improve Quality of OGD

The Use of Artificial Intelligence Real-time Feedback to Improve Compliance to a Standardised Protocol and Procedural Quality During Oesophagogastroduodenoscopy (OGD)

Status
Unknown
Phase
Study type
Observational
Enrollment
210 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Early and accurate recognition of gastrointestinal lesions has implications for public health. The quality of oesophagogastroduodenoscopy (OGD) has great impact on the detection of oesophageal and gastric malignancies. An AI system, Cerebro, has been developed as a real-time recognition of a pre-defined 28 locations. This system would alert the endoscopist if the sites were not inspected with adequate time. The aim of the study is to investigate the use of AI in endoscopists-in-training during OGD to provide a real-time feedback for ensuring compliance to a standardized protocol for examination. The hypothesis is that the use of AI system Cerebro will significantly improve the compliance to the protocol and thereby reduce the blind spot rates of OGD, ensure adequate inspection time and ensure adequate photodocumentation.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTThe use of artificial intelligence system CerebroThe artificial intelligence system Cerebro would be used during OGD

Timeline

Start date
2021-05-01
Primary completion
2021-12-31
Completion
2022-06-30
First posted
2021-05-12
Last updated
2021-05-12

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT04883567. Inclusion in this directory is not an endorsement.